Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Biomarkers in colon cancer: the chasm between expectations and reality.

Van Loon K, Venook AP.

Oncology (Williston Park). 2013 Aug;27(8):758, 763. No abstract available.

2.

Personalized medicine in the adjuvant chemotherapy of stage II colon cancer--are we there yet?

Lee JJ, Chu E.

Oncology (Williston Park). 2013 Aug;27(8):754, 756-8. No abstract available.

3.

Use of molecular biomarkers to inform adjuvant therapy for colon cancer.

Mettu NB, Hurwitz H, Hsu DS.

Oncology (Williston Park). 2013 Aug;27(8):746-54. Review.

4.

Oncotype DX(®) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence.

You YN, Rustin RB, Sullivan JD.

Surg Oncol. 2015 Jun;24(2):61-6. doi: 10.1016/j.suronc.2015.02.001. Epub 2015 Feb 14. Review.

PMID:
25770397
5.

Local recurrence after curative resection in patients with colon and rectal cancers.

Yun HR, Lee LJ, Park JH, Cho YK, Cho YB, Lee WY, Kim HC, Chun HK, Yun SH.

Int J Colorectal Dis. 2008 Nov;23(11):1081-7. doi: 10.1007/s00384-008-0530-0. Epub 2008 Aug 8.

PMID:
18688621
6.

The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life.

Winkels RM, Heine-Bröring RC, van Zutphen M, van Harten-Gerritsen S, Kok DE, van Duijnhoven FJ, Kampman E.

BMC Cancer. 2014 May 27;14:374. doi: 10.1186/1471-2407-14-374.

7.

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

Shariat SF, Karakiewicz PI, Ashfaq R, Lerner SP, Palapattu GS, Cote RJ, Sagalowsky AI, Lotan Y.

Cancer. 2008 Jan 15;112(2):315-25.

8.

LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.

Liu D, Baltayan A, Naritoku WY, Barr NJ, Young LL, Chaiwun B, Tsao-Wei DD, Groshen SL, Taylor CR, Torloni H, Neville AM, Cote RJ, Imam SA.

Anticancer Res. 2000 May-Jun;20(3A):1451-61.

PMID:
10928056
9.

Crossing the quality chasm in breast cancer care.

Silliman RA.

J Clin Oncol. 2004 Sep 15;22(18):3654-6. Epub 2004 Aug 2. No abstract available.

PMID:
15289489
10.

Biomarkers for lung cancer: clinical uses.

Greenberg AK, Lee MS.

Curr Opin Pulm Med. 2007 Jul;13(4):249-55. Review.

PMID:
17534168
11.

Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.

Gill S, Haince JF, Shi Q, Pavey ES, Beaudry G, Sargent DJ, Fradet Y.

Clin Colorectal Cancer. 2015 Jun;14(2):99-105. doi: 10.1016/j.clcc.2014.12.005. Epub 2014 Dec 24.

PMID:
25619805
12.

[Local recurrence caused by direct implantation from cancer of the colon; findings of a case report].

Pisano G, Ghinami E, Faa G, Cagetti M.

G Chir. 1991 May;12(5):316-8. Italian.

PMID:
1931523
13.

Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis.

Chou R, Gore JL, Buckley D, Fu R, Gustafson K, Griffin JC, Grusing S, Selph S.

Ann Intern Med. 2015 Dec 15;163(12):922-31. doi: 10.7326/M15-0997. Epub 2015 Dec 15. Review.

PMID:
26501851
14.

Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.

Weissmann-Brenner A, Kushnir M, Lithwick Yanai G, Aharonov R, Gibori H, Purim O, Kundel Y, Morgenstern S, Halperin M, Niv Y, Brenner B.

Int J Oncol. 2012 Jun;40(6):2097-103. doi: 10.3892/ijo.2012.1403. Epub 2012 Mar 16.

PMID:
22426940
15.

Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.

Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.

Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043. Epub 2013 Apr 3.

PMID:
23571005
16.

What is the effect of laparoscopic colectomy on pattern of colon cancer recurrence? A propensity score and competing risk analysis compared with open colectomy.

Hasegawa H, Okabayashi K, Watanabe M, Ashrafian H, Harling L, Ishii Y, Sugiyama D, Seishima R, Darzi A, Athanasiou T, Kitagawa Y.

Ann Surg Oncol. 2014 Aug;21(8):2627-35. doi: 10.1245/s10434-014-3613-x. Epub 2014 Mar 11.

PMID:
24615179
17.

Incidence and patterns of late recurrences in colon cancer patients.

Bouvier AM, Launoy G, Bouvier V, Rollot F, Manfredi S, Faivre J, Cottet V, Jooste V.

Int J Cancer. 2015 Nov 1;137(9):2133-8. doi: 10.1002/ijc.29578. Epub 2015 May 6.

18.

Detection of cervical cancer recurrence during follow-up: a multivariable comparison of 9 frequently investigated serum biomarkers.

Hoogendam JP, Zaal A, Rutten EG, Heijnen CJ, Kenter GG, Veldhuis WB, Verheijen RH, Zweemer RP.

Gynecol Oncol. 2013 Dec;131(3):655-60. doi: 10.1016/j.ygyno.2013.10.016. Epub 2013 Oct 22.

PMID:
24157617
19.

Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.

Zhang H, Ge T, Cui X, Hou Y, Ke C, Yang M, Yang K, Wang J, Guo B, Zhang F, Lou G, Li K.

Mol Biosyst. 2015 Feb;11(2):516-21. doi: 10.1039/c4mb00407h. Epub 2014 Nov 26.

PMID:
25424060
20.

Patterns of recurrence of obstructing colon cancers after surgery for cure: a population-based study.

Cortet M, Grimault A, Cheynel N, Lepage C, Bouvier AM, Faivre J.

Colorectal Dis. 2013 Sep;15(9):1100-6. doi: 10.1111/codi.12268.

PMID:
23634749

Supplemental Content

Support Center